Retrospective Study
Copyright ©The Author(s) 2017.
World J Nephrol. Sep 6, 2017; 6(5): 229-235
Published online Sep 6, 2017. doi: 10.5527/wjn.v6.i5.229
Table 1 Characteristics of the 293 studied infants, n (%) unless stated otherwise
Males142 (48)
Birth weight (g): median (range)1130 (450-1860)
Gestational age (mean, SD)28.7 (2.8)
Mode of delivery
Vaginal delivery53 (18)
Cesarean section240 (82)
Maternal steroids217 (74)
Intraventricular hemorrhage
Grade 116 (5)
Grade 210 (3)
Grade 313 (5)
Grade 416 (5)
Periventricular leukomalacia12 (4)
Necrotizing enterocolitis30 (10)
Patent ductus arteriosus
Tiny34 (11)
Moderate39 (13)
Large25 (8)
Sepsis
Clinical sepsis61 (21)
Sepsis with normotension24 (8)
Sepsis with hypotension26 (9)
Duration of mechanical ventilation (d): median (range)3 (1-410)
Surgery required22 (7)
Inotrope use59 (20)
Ibuprofen use63 (21)
Vancomycin use84 (29)
Gentamycin use203 (69)
Post natal Steroids use38 (13)
Umbilical arterial catheter use158 (54)
Oliguria
< 0.5 mL/kg per hour for 6 h3 (1)
< 0.3 mL/kg per hour for 24 h10 (3)
Hypotension58 (20)
Normal saline intravenous bolus50 (17)
Furosemide12 (4)
Duration of hospital stay (d): median (range)49 (1-480)
Acute kidney injury
Stage 16 (2)
Stage 212 (4)
Stage 316 (5)
Mortality46 (17)
Table 2 Stages of acute kidney injury in 34 infants by birth weight n (%)
AKI stagesBirth weight
Total n = 293
1000 g n = 184< 1000 g n = 109
12 (1.0)4 (3.7)6 (2.0)
23 (1.6)9 (8.2)12 (4.1)
35 (2.7)11 (10.1)16 (5.4)
Total10 (5.4)24 (22.0)34 (11.6)
Table 3 Patients with or without acute kidney injury, n (%) unless stated otherwise
No AKI n = 259Stage 1 AKI n = 6Stage 2 AKI n = 12Stage 3 AKI n = 16Univariate analysis P valueMultivariate analysis4P value
Males122 (47)4 (67)7 (58)9 (56)0.61NS
Birth weight (g): mean (SD)1130 (267)976 (271)791 (257)850 (253)< 0.0012NS
Gestational age (wk): median (range)29.0 (22-35)28.0 (23-32)25.0 (23-30)25.5 (23-38)< 0.0013NS
Mode of delivery0.031NS
Vaginal delivery40 (15)1 (17)3 (25)9 (56)NS
Cesarean section219 (84)5 (83)9 (75)7 (43)NS
Maternal steroids193 (74)5 (83)8 (67)11 (69)0.91NS
Intraventricular hemorrhage< 0.0011NS
Grade 115 (6)1 (16)0 (0)0 (0)NS
Grade 28 (3)1 (16)0 (0)1 (6)NS
Grade 39 (3)1 (16)1 (8)2 (13)NS
Grade 49 (4)0 (0)1 (8)6 (40)NS
Necrotizing enterocolitis16 (6)1 (16)6 (50)7 (43)< 0.00110.001
Patent ductus arteriosus0.031NS
Tiny29 (11)1 (16)1 (8)3 (18)NS
Moderate32 (12)0 (0)3 (25)4 (25)NS
Large19 (7)1 (16)3 (25)2 (12)NS
Sepsis< 0.0011NS
Clinical sepsis45 (17)3 (50)6 (50)7 (43)NS
Sepsis with normotension22 (8)1 (16)0 (0)1 (6)NS
Sepsis with hypotension14 (5)1 (16)6 (50)5 (31)NS
Duration of mechanical ventilation (d): median (range)2 (1-160)3.5 (1-29)17.5 (7-71)13 (2-262)< 0.0013NS
Surgery required11 (4)1 (16)4 (33)6 (37)< 0.0011NS
Inotrope use37 (14)2 (33)8 (66)12 (75)< 0.0011NS
Ibuprofen use51 (19)1 (16)7 (58)4 (25)0.011NS
Vancomycin use59 (22)3 (50)10 (83)12 (75)< 0.0011NS
Gentamycin use173 (66)5 (83)11 (91)14 (87)0.081NS
Steroids use24 (9)1 (16)6 (50)7 (43)< 0.0011NS
Umbilical arterial catheter use129 (49)5 (83)8 (66)16 (100)< 0.0011NS
Oliguria< 0.0011NS
< 0.5 mL/kg per hour for 6 h0 (0)0 (0)1 (8)2 (12)NS
< 0.3 mL/kg per hour for 24 h0 (0)1 (16)3 (25)6 (37)NS
Hypotension35 (13)2 (33)9 (75)12 (75)< 0.0011NS
Normal saline intravenous bolus28 (10)2 (33)9 (75)11 (68)< 0.0011NS
Furosemide4 (1)1 (16)3 (25)4 (25)< 0.0011NS
Duration of hospital stay in survivors (d): median (range)52 (15-280)64.5 (53-125)74.5 (7-116)116 (44-362)0.023NS
Mortality27 (10)2 (33)8 (66)9 (56)< 0.0011NS
Serum creatinine (µmol/L) on discharge: median (range)44 (23)64 (56)93 (47)133 (135)< 0.0013NS
Mean blood pressure (mmHg) on discharge: median (range)55 (13)48 (24)38 (13)41 (19)< 0.0013NS
Table 4 Outcomes, n (%) unless stated otherwise
No AKI n = 259Any stage AKI n = 34P value
Length of stay in survivors: median (range)
BW ≤ 1000 g (n = 108)82 (37-280)112 (7-362)0.32
BW > 1000 g (n = 184)40 (15-149)53 (35-137)0.0032
Mortality of any cause
BW ≤ 1000 g (n = 108)18 (21)14 (58)< 0.0011
BW > 1000 g (n = 184)9 (5)5 (50)< 0.0011